首页> 外文期刊>The Journal of Urology >Management of Severe Urethral Complications of Prostate Cancer Therapy
【24h】

Management of Severe Urethral Complications of Prostate Cancer Therapy

机译:前列腺癌严重尿道并发症的治疗

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose: We present our management of urethral stenosis and rectourinary fistula resulting from prostate cancer therapy We concentrated on cases refractory to minimally invasive treatment, such as dilation, urethrotomy, and urinary and/or fecal diversion.Materials and Methods: In our prospectively collected urethral reconstruction database we identified patients who underwent reconstruction of urethral stenosis or rectourinary fistula who also received prior treatment for prostate cancer We documented demographics, prostate cancer pretreatment characteristics, prostate cancer therapy type, urethral recon-struction type and success.Results: A total of 48 patients met the inclusion criteria, including 16 with rectourinary fistula and 32 with urethral stenosis Urethral complications followed prior radical prostatectomy, brachytherapy, external beam radiotherapy, cryotherapy thermal ablation and any combination of these procedures. Stenosis repair was successful in 23 of 32 cases (73%) and it differed little between anterior and posterior urethral stenosis. Repair was accomplished by anastomotic urethroplasty in 19 cases, flap urethroplasty in 2, perineal urethrostomy in 2 and a urethral stent in 9. Prior external beam radiotherapy was a risk factor for urethral reconstruction failure. Fistula repair was successful in 14 of 15 patients (93%), excluding 1 who died postoperatively. The complexity of fistula management was dictated by fistula size and the presence or absence of coincident urethral stenosis.Conclusions: Urethral stenosis or rectourethral fistula following prostate cancer therapy can be managed by urethral reconstruction, such that normal voiding via the urethra is maintained, rather than abandoning the urethral outlet and performing heterotopic diversion. This can be accomplished with an acceptable rate of failure, given the complexity of the cases.
机译:目的:我们介绍对前列腺癌治疗引起的尿道狭窄和直肠瘘的治疗方法。我们主要研究微创治疗难以治疗的病例,例如扩张,尿道切开术,尿液和/或粪便改道。材料和方法:在我们前瞻性收集的尿道中重建数据库,我们确定了接受过尿道狭窄或直肠瘘重建的患者,并且他们也接受过前列腺癌的治疗。我们记录了人口统计学,前列腺癌的预处理特征,前列腺癌的治疗类型,尿道重建类型和成功案例。结果:总共48例患者符合入选标准,其中16例患有直肠瘘,32例患有尿道狭窄。事先进行前列腺癌根治术,近距离放射治疗,体外放射线疗法,冷冻疗法热消融以及这些程序的任意组合后,出现了尿道并发症。狭窄修复成功32例,其中23例(73%),前后尿道狭窄之间的差异不大。修复是通过吻合口尿道成形术19例,皮瓣尿道成形术2例,会阴尿道造口术2例和尿道支架9例来完成的。先前的体外束放射疗法是尿道重建失败的危险因素。 15例患者中有14例(93%)成功进行了瘘管修复,其中1例术后死亡。瘘管治疗的复杂性取决于瘘管的大小以及是否存在尿道狭窄。结论:前列腺癌治疗后的尿道狭窄或直肠外瘘可以通过尿道重建来控制,这样可以维持正常的排尿而不是通过尿道放弃尿道出口并进行异位转移。考虑到案例的复杂性,可以通过可接受的失败率来完成此任务。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号